Srs Capital Advisors, Inc. Biocryst Pharmaceuticals Inc Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 738 shares of BCRX stock, worth $6,634. This represents 0.0% of its overall portfolio holdings.
Number of Shares
738
Previous 738
-0.0%
Holding current value
$6,634
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BCRX
# of Institutions
285Shares Held
172MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA21.9MShares$197 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$179 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$107 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$81.7 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$79.6 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.67B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...